AAA Analysis – Page 106

Summer slowdown

Over the summer months of July and August we tracked a total of 235 investment deals involving corporate venture investors, with an estimated $9.87bn of total capital involved. More than half of all tracked deals (142) took place in the US. Other important investment geographies were China (24) and India (16). The number of deals… Continue reading Summer slowdown

Big Deal: GSK seeks truth with Alphabet

Three years ago, in August 2013, Global Corporate Venturing’s Big Deal analysis said: “GSK electrifies with first deal” referring to UK-based drugs maker GlaxoSmithKline’s $50m bioelectronics fund, Action Potential Venture Capital (APVC). That deal was for SetPoint Medical, which subsequently raised a $43m series C round last year also including APVC. APVC’s other portfolio companies… Continue reading Big Deal: GSK seeks truth with Alphabet